Pharmaceuticals (147) | Registration Rights Agreements (147)
Browse by Company
-
Acacia Diversified Holdings, Inc. (1)
-
Acer Therapeutics Inc. (1)
-
Aclaris Therapeutics, Inc. (1)
-
Acreage Holdings, Inc. (1)
-
ADIAL PHARMACEUTICALS, INC. (4)
-
Aerpio Pharmaceuticals, Inc. (1)
-
Akers Biosciences, Inc. (1)
-
ALIMERA SCIENCES INC (1)
-
Angion Biomedica Corp. (1)
-
Aquestive Therapeutics, Inc. (1)
-
ARTELO BIOSCIENCES, INC. (1)
-
ARVINAS, INC. (1)
-
AVADEL PHARMACEUTICALS PLC (2)
-
AVENUE THERAPEUTICS, INC. (1)
-
AYTU BIOSCIENCE, INC (2)
-
Big Rock Partners Acquisition Corp. (4)
-
Biofrontera Inc. (2)
-
BioPharmX Corp (1)
-
Blue Water Acquisition Corp. (5)
-
Boston Therapeutics, Inc. (1)
-
Canbiola, Inc. (3)
-
Cannabics Pharmaceuticals Inc. (1)
-
CANNAPHARMARX, INC. (1)
-
Catalent Inc (1)
-
Cerecor Inc. (2)
-
Citius Pharmaceuticals, Inc. (1)
-
Clearside Biomedical, Inc. (1)
-
Clever Leaves Holdings Inc. (1)
-
CNS Pharmaceuticals, Inc. (2)
-
Context Therapeutics Inc. (1)
-
CorMedix Inc. (1)
-
Cure Pharmaceutical Holding Corp. (1)
-
Dermata Therapeutics, Inc. (1)
-
ELITE PHARMACEUTICALS INC (1)
-
Endexx Corp (1)
-
Evofem Biosciences, Inc. (3)
-
Evolus, Inc. (1)
-
Exactus, Inc. (3)
-
EYEGATE PHARMACEUTICALS INC (3)
-
EYENOVIA, INC. (1)
-
Fulcrum Therapeutics, Inc. (1)
-
GREEN HYGIENICS HOLDINGS INC. (3)
-
Hoth Therapeutics, Inc. (3)
-
IMAGING3 INC (1)
-
INNOVATE BIOPHARMACEUTICALS, INC. (1)
-
Intersect ENT, Inc. (1)
-
Jaguar Health, Inc. (4)
-
Kala Pharmaceuticals, Inc. (1)
-
KEMPHARM, INC (3)
-
Lexaria Bioscience Corp. (1)
-
Liquidia Corp (1)
-
Liquidia Technologies Inc (1)
-
Lyra Therapeutics, Inc. (1)
-
Marijuana Co of America, Inc. (1)
-
Menlo Therapeutics Inc. (1)
-
MICROCHANNEL TECHNOLOGIES CORP (3)
-
Milestone Pharmaceuticals Inc. (1)
-
MYnd Analytics, Inc. (1)
-
Nabriva Therapeutics plc (1)
-
Neos Therapeutics, Inc. (1)
-
Neuralstem, Inc. (1)
-
NovaBay Pharmaceuticals, Inc. (1)
-
Novan, Inc. (3)
-
OCULAR THERAPEUTIX, INC (2)
-
OPIANT PHARMACEUTICALS, INC. (1)
-
Panacea Acquisition Corp (3)
-
Petros Pharmaceuticals, Inc. (1)
-
Pharmagreen Biotech Inc. (1)
-
PLAYERS NETWORK (1)
-
PLx Pharma Inc. (2)
-
Processa Pharmaceuticals, Inc. (1)
-
QUANTA INC (2)
-
Rani Therapeutics Holdings, Inc. (2)
-
Recro Pharma, Inc. (1)
-
RELMADA THERAPEUTICS, INC. (2)
-
RespireRx Pharmaceuticals Inc. (2)
-
resTORbio, Inc. (2)
-
Roivant Sciences Ltd. (1)
-
Royalty Pharma plc (5)
-
Satsuma Pharmaceuticals, Inc. (1)
-
Scopus BioPharma Inc. (2)
-
SCYNEXIS INC (1)
-
SenesTech, Inc. (1)
-
TAURIGA SCIENCES, INC. (2)
-
Tenzing Acquisition Corp. (1)
-
Terra Tech Corp. (2)
-
TETRAPHASE PHARMACEUTICALS INC (1)
-
TEVA PHARMACEUTICAL INDUSTRIES LTD (2)
-
TFF Pharmaceuticals, Inc. (2)
-
Theravance Biopharma, Inc. (2)
-
Trulieve Cannabis Corp. (1)
-
Xeris Biopharma Holdings, Inc. (1)
Recent Contracts
-
Third Amended and Restated Registration Rights Agreement, dated as of May 1, 2021, by and among Roivant Sciences Ltd. and the parties thereto
(Roivant Sciences Ltd., Filed With SEC on June 28, 2022)
-
Registration Rights Agreement, by and between the Company and Dutchess Capital Growth Fund LP, dated May 31, 2022
(Marijuana Co of America, Inc., Filed With SEC on June 3, 2022)
-
Form of Registration Rights Agreement
(Biofrontera Inc., Filed With SEC on May 20, 2022)
-
Registration Rights Agreement between Artelo Biosciences, Inc. and Lincoln Park Capital Fund, LLC, dated May 13, 2022
(ARTELO BIOSCIENCES, INC., Filed With SEC on May 16, 2022)
-
Form of Registration Rights Agreement dated April 20, 2022 between the Company and the Purchaser
(Dermata Therapeutics, Inc., Filed With SEC on April 25, 2022)
-
Piggy-back Registration Rights Agreement dated April 14, 2022 between RespireRx Pharmaceuticals Inc. and Barton Asset Management LLC
(RespireRx Pharmaceuticals Inc., Filed With SEC on April 15, 2022)
-
Registration Rights Agreement, dated as of April 7, 2022, by and among Lyra Therapeutics, Inc. and the Investors named therein
(Lyra Therapeutics, Inc., Filed With SEC on April 13, 2022)
-
Registration Rights Agreement, dated as of April 12, 2022, by and between the Company and Lincoln Park
(Aquestive Therapeutics, Inc., Filed With SEC on April 13, 2022)
-
Registration Rights Agreement, effective as of August 3, 2021
(Rani Therapeutics Holdings, Inc., Filed With SEC on March 31, 2022)
-
Registration Rights Agreement, dated March 23, 2022, by and between Processa Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC
(Processa Pharmaceuticals, Inc., Filed With SEC on March 24, 2022)